South and Central America Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Drugs (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot, and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)
Market Introduction
The South and Central America joint pain injection market is a highly fragmented market with the presence of considerable regional and local players providing numerous solutions for companies investing in the market arena. The countries in the region are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Some of the major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the market’s growth. The countries are growing domestic productions for pharmaceutical productions. Flourishing domestic pharmaceutical market in South and Central America and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies.
Brazil witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market. A considerable number of countries in South America have very underdeveloped healthcare infrastructure. In addition, the availability of joint pain injections in the region is also significantly lower. For instance, Peru, has less than 1000 intensive care unit beds for its 32 million inhabitants. Furthermore, supply chain disruption caused due to congestion of ports and disturbances in other transport means had substantial impact on the distribution of joint pain injections in the region. All these factors considerably deterred the growth of South and Central America joint pain injections market.
Get more information on this report :
Market Overview and Dynamics
The joint pain injection market in South and Central America is expected to grow from US$ 124.78 million in 2021 to US$ 199.41 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. Brazil is the fifth largest country in the world both by area and by population and experiencing the fastest demographic aging worldwide. In Brazil, the aging population is at a rapid pace and in a context of regional and historical socioeconomic inequalities. According to the study conducted in Brazil, the community of women estimated at the vast majority with 16.9 million (56%) of elderly persons, whereas older adults estimated approx. 13.3 million (44%). The growing aging population leads and increasing incidence of orthopedic diseases. Such growing conditions are likely to drive the adoption of medical devices, which will eventually drive the Brazil joint pain injection market during the forecast period. Similar to Brazil, Argentina is also the largest country in the region. The country has a vital role to play in the medical equipment industry. The country has to experience development in the private and public healthcare sectors. Further, Argentina is strengthening its human resources with highly skilled professionals across all the healthcare sectors. Argentina offers high-quality health services, which are considered among the best in Latin America. In cities, Buenos Aires, Córdoba, or Mendoza, hospitals, and clinics have advanced infrastructure with competent medical staff. Thus, it is expected that the country owes significant growth opportunities for the market.
Key Market Segments
Based on drugs, the hyaluronic acid segment accounted for the largest share of the South and Central America joint pain injection market in 2020. Based on joint type, the knee segment accounted for the largest share of the South and Central America joint pain injection market in 2020. Based on distribution channel, the hospitals pharmacies segment accounted for the largest share of the South and Central America joint pain injection market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the South and Central America joint pain injection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report include Bioventus Inc.; Fidia Pharma USA Inc.; Seikagaku Corporation; Ferring B.V.; Sanofi; Anika Therapeutics, Inc; and Teva Pharmaceutical Industries Ltd.
Reasons to buy report
- To understand the South and Central America joint pain injection market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America joint pain injection market
- Efficiently plan M&A and partnership deals in South and Central America joint pain injection market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America joint pain injection market
- Obtain market revenue forecast for market by various segments from 2020-2028 in South and Central America region.
South and Central America Joint Pain Injection Market Segmentation
South and Central America Joint Pain Injection Market -By Drugs
- Hyaluronic Acid
- Corticosteroid
- Others
South and Central America Joint Pain Injection Market -By Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
South and Central America Joint Pain Injection Market -By Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
South and Central America Joint Pain Injection Market – By Country
- Brazil
- Argentina
- Rest of South and Central America
South and Central America Joint Pain Injection Market – Company Profiles
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Joint Pain Injection Market – By Drugs
1.3.2 South and Central America Joint Pain Injection Market – By Joint Type
1.3.3 South and Central America Joint Pain Injection Market – By Distribution Channel
1.3.4 South and Central America Joint Pain Injection Market – By Country
2. South and Central America Joint Pain Injection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Joint Pain Injection – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Joint Pain Injection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Instances of Musculoskeletal Disorders
5.1.2 Proliferation in the Number of Sport Injuries
5.2 Market Restraints
5.2.1 High Costs of Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Expansion of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 High Focus on Product Innovation
5.5 Impact Analysis
6. Joint Pain Injection Market – South and Central America Analysis
6.1 South and Central America Joint Pain Injection Market Revenue Forecast and Analysis
6.2 South and Central America Joint Pain Injection Market, By Country - Forecast and Analysis
7. South and Central Joint Pain Injection Market Analysis – By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8. South and Central America Joint Pain Injection Market Analysis – By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9. South and Central America Joint Pain Injection Market Analysis – By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
10. South and Central America Joint Pain Injection Market – Country Analysis
10.1 South and Central America: Joint Pain Injection Market Revenue and Forecast to 2028
10.1.1 South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.1.2 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Brazil: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.2.3 Brazil: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.2.4 Brazil: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.3 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 Argentina: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.3.3 Argentina: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.3.4 Argentina: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 Rest of South and Central America: Joint Pain Injection Market- Revenue and Forecasts to 2027 (USD Million)
10.1.4.1 Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Rest of South and Central America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.4.3 Rest of South and Central America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.4.4 Rest of South and Central America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on South and Central America Joint Pain Injection Market
11.1 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Joint Pain Injection Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Bioventus Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fidia Pharma USA Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Seikagaku Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Ferring B.V.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Anika Therapeutics, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Teva Pharmaceutical Industries Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Joint Pain Injection Market –Revenue and Forecast To 2028 (US$ Million)
Table 2. Brazil Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of South and Central America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South and Central America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done By Companies
Table 13. Glossary of Terms, Joint Pain Injection Market
LIST OF FIGURES
Figure 1. Joint Pain Injection Market Segmentation
Figure 2. South and Central America Joint Pain Injection Market Segmentation, By Country
Figure 3. Joint Pain Injection Market Overview
Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South and Central America Joint Pain Injection Market, Industry Landscape
Figure 7. South and Central America (SCAM) PEST Analysis
Figure 8. Joint Pain Injection Market Impact Analysis of Driver and Restraints
Figure 9. South and Central America Joint Pain Injection Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
Figure 11. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
Figure 15. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)
Figure 21. Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South and Central America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 25. South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 26. Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 30. Growth Strategies Done by the Companies in the Market, (%)
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South and Central America joint pain injection market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the South and Central America joint pain injection market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution